Agreed and cogent points from you as always Harry thank you - time will tell of course.
So far I am minded to place my trust in James Marsh 100%. By this I mean that - as I have stipulated many times previously his input and management is beyond outstanding. In my view management is the apex of any investment and all else follows.
However, ceramics has been touted publicly as the foundation of ADN’s business case and, until I hear from the company that it is no longer part of its business case (which has not been announced and indeed would be contrary to recent announcements) will continue to assume it is.
As you well know, I am super-bullish on the concrete additive; Nanotech; hydrogen storage aspects of ADN’s play and fully supportive of the same where commercially feasible options exist.
Very best to all ADN shareholders.
- Forums
- ASX - By Stock
- ADN
- General comments/chat
General comments/chat, page-12857
-
-
- There are more pages in this discussion • 31,225 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADN (ASX) to my watchlist
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $49.76M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.5¢ | $92.09K | 5.787M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 3456624 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 190908 | 0.016 |
43 | 7873041 | 0.015 |
15 | 5136049 | 0.014 |
7 | 2633923 | 0.013 |
6 | 1655833 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 3456624 | 11 |
0.018 | 2962774 | 10 |
0.019 | 3659762 | 9 |
0.020 | 1678444 | 14 |
0.021 | 1397619 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ADN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online